Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...

An investigational blood test for type 1 diabetes can accurately detect the disorder's characteristic autoimmunity with only ...

Researchers explore the medicinal role of curcumin in the treatment and prevention of neuroinflammation and metabolic ...

For a long time, scientists thought that vitamin B12 might help lower inflammation, but they weren’t exactly sure how. This ...

The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).

Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

Healio spoke with Raj Chovatiya, MD, PhD, about results from the phase 3 ICONIC-LEAD trial presented at the 2025 Academy of ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

Recent years have seen significant advancements in UC treatment, offering renewed hope for patients seeking effective and ...

Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Avalo’s lead asset is AVTX-09, an anti-IL-1ß mAb, targeting inflammatory diseases. For ...

Updated findings from a phase 2 study investigating the IL-2–binding monoclonal antibody AU-007 show a manageable safety ...